Home/Filings/4/0001209191-22-027840
4//SEC Filing

Lamb Lawrence 4

Accession 0001209191-22-027840

CIK 0001740279other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:25 PM ET

Size

7.1 KB

Accession

0001209191-22-027840

Insider Transaction Report

Form 4
Period: 2022-05-05
Lamb Lawrence
EVP and CSO
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2022-05-0526,2041,171 total
    Exercise: $1.07Exp: 2028-11-11Common Stock (26,204 underlying)
  • Exercise/Conversion

    Common Stock

    2022-05-05$1.07/sh+26,204$27,99999,204 total
Footnotes (1)
  • [F1]The shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments commencing June 7, 2018, subject to the Reporting Person continuing to provide service through each such date.

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1
  • filerCIK 0001830059

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:25 PM ET
Size
7.1 KB